Health Care & Life Sciences » Pharmaceuticals » Biotechnology industry | U.S. biotech commercial leaders vs other companies 2016

Commercial leaders vs. other companies in U.S. biotech 2016

Commercial leaders vs. other companies in U.S. biotechnology in 2016

The data illustrates a comparison of commercial leaders vs. other companies in U.S. biotechnology in 2016. In that year, the revenues of commercial leaders amounted to around 99 billion USD, while the revenues of other companies in this sector came to some 13.4 billion USD.

Revenues (in billion US$)	98.8	13.4
R&D expenses (in billion US$)	21.9	16.9
Net income (in billion US$)	29.1	-19.9
Market capitalization (in billion US$)	522	176.7
Number of employees	87930	47800

Commercial leaders vs. other companies in U.S. biotech 2016

StatInvestor